04 September 2010
Keywords: Eli Lilly, Kyowa, Livalo, Statin, Licensing, USA, Latin America
Article | 24 December 2009
US drug major Eli Lilly has signed an accord with Kowa Pharmaceuticals America, the US subsidiary of Japan’s Kyowa, to commercialize Livalo (pitavastatin). The companies have also entered into a licensing agreement in Latin America. Financial terms of the deal have not been disclosed.
L Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.
FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!
Sign up in less than 60 seconds...no payment needed
Take a no obligations 30 day trial.
Only one trial per user. Find out more details
Subscriptions are £60 per month, pay as you go.
Find out more details.